Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
Celecoxib has potential as an effective antineoplastic agent, but it may exhibit side effects. Given the glucose-addicted properties of tumor cells, metformin is recognized for its inhibitory effect on oxidative phosphorylation. In the present study, we aimed to combine low dose of celecoxib with me...
Saved in:
Main Authors: | Nini Cao (Author), Yanyan Lu (Author), Jia Liu (Author), Fangfang Cai (Author), Huangru Xu (Author), Jia Chen (Author), Xiangyu Zhang (Author), Zi-Chun Hua (Author), Hongqin Zhuang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway In vitro and In vivo
by: Fangfang Cai, et al.
Published: (2021) -
Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
by: Immacolata Maietta, et al.
Published: (2022) -
The synergistic antitumor effect of Huaier combined with 5-Florouracil in human cholangiocarcinoma cells
by: Zhaoyu Fu, et al.
Published: (2019) -
Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells
by: Una Glamoclija, et al.
Published: (2022) -
Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer
by: Yi L, et al.
Published: (2018)